Israeli companies chosen for MedTech Innovator Showcase
Medasense for pain management and Vectorious for heart-failure monitoring were among 50 companies selected from a field of 800 applicants.
Medasense for pain management and Vectorious for heart-failure monitoring were among 50 companies selected from a field of 800 applicants.
Projects receiving Horizon 2020 funding include wireless heart implant, sustainable water reuse applications and drug delivery platform.
Heart failure, kidney disease, sleep apnea, diabetes, back pain – disruptive medical devices emerging from Israel could transform treatment for these conditions.
Israeli companies design devices for the many patients whose left-side heart chambers aren’t functioning well.
Endor receives $45m in an ICO; Medial EarlySign raises $30m; Capitolis, ReWalk Robotics and ContinUse Biometrics each garner $20m.